Company name
KLINRISK
Stage Invested
Series B 2024
Company Description:
At Klinrisk, we know the only way to meaningfully impact chronic condition management is to create scalable solutions that fit within existing provider and lab systems.
Advanced analysis of routine lab tests holds untapped insights for providers and patients.
We hold our technology to the highest scientific and regulatory standards so patient care isn’t compromised.
Website:
KLINRISK in the news:
Check back soon!